The L1CAM gene plays a crucial role in the nervous system's development, particularly in the brain and spinal cord. Mutations in the L1CAM gene are associated with MASA syndrome, a rare genetic disorder that affects the development of the nervous system, leading to a range of symptoms including intellectual disability, aphasia, shuffling gait, and adducted thumbs. MASA is an acronym for the key features of the syndrome: Mental retardation, Aphasia, Shuffling gait, and Adducted thumbs.
To diagnose MASA syndrome, genetic testing of the L1CAM gene is essential. DNA Labs UAE offers a comprehensive genetic test for the L1CAM gene to identify mutations that could indicate MASA syndrome. This test is crucial for families seeking answers to developmental delays and neurological symptoms in their children, providing them with a clear diagnosis and the possibility of genetic counseling.
The cost of the L1CAM gene MASA syndrome genetic test at DNA Labs UAE is 4400 AED. This test is conducted with the utmost confidentiality and accuracy, using state-of-the-art technology to ensure reliable results. Families and individuals opting for this test at DNA Labs UAE can expect professional guidance throughout the testing process, from sample collection to the interpretation of results.
The XK Gene McLeod syndrome with or without chronic granulomatous disease Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify genetic mutations associated with McLeod syndrome, a rare condition that affects various systems in the body, including the nervous system, blood, and muscles. This syndrome can sometimes occur in conjunction with chronic granulomatous disease, an immune disorder that leads to recurrent infections and granuloma formation. The test specifically looks for abnormalities in the XK gene, which is crucial for the proper functioning of the Kx protein, involved in the development of these conditions. With a cost of 4400 AED, this genetic test is a critical tool for early diagnosis and management, helping healthcare providers to tailor appropriate treatment plans for affected individuals. By conducting this test at DNA Labs UAE, patients are ensured accurate, reliable results, leveraging state-of-the-art technology and expertise in genetic diagnostics.
The MLC1 Gene Megalencephalic Leukoencephalopathy with Subcortical Cysts Genetic Test is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to identify mutations in the MLC1 gene, which are linked to the development of Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC). MLC is a rare neurological disorder characterized by an enlarged brain (megalencephaly), abnormalities in the white matter of the brain (leukoencephalopathy), and the formation of fluid-filled cysts in certain areas of the brain. Early diagnosis through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals. The test is priced at 4400 AED and is conducted with precision and care at DNA Labs UAE, offering crucial insights for individuals and families affected by this condition.
The HEPACAM Gene Megalencephalic Leukoencephalopathy with Subcortical Cysts 2A (MLC2A) genetic test is a diagnostic examination performed to detect mutations in the HEPACAM gene, which are responsible for the development of MLC2A, a rare neurological disorder. This condition is characterized by an abnormal enlargement of the brain (megalencephaly) and the presence of cysts within the white matter of the brain, leading to a range of neurological symptoms including motor dysfunction, epilepsy, and cognitive delays.
DNA Labs UAE offers this specific genetic test at a cost of 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any mutations in the HEPACAM gene. This genetic testing is crucial for the accurate diagnosis of MLC2A, enabling healthcare professionals to provide appropriate management and treatment plans for affected individuals. Moreover, it can also offer valuable information for family planning to those who have a history of MLC2A in their family.
The MT-TL1 gene is closely associated with MELAS syndrome, a mitochondrial disorder characterized by mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. Mutations in the MT-TL1 gene, which is responsible for mitochondrial tRNA leucine 1, can lead to impaired mitochondrial protein synthesis, affecting cellular energy production. This has significant implications for the nervous system and muscles, leading to the symptoms observed in MELAS syndrome.
To diagnose and understand the genetic basis of MELAS syndrome in affected individuals, genetic testing targeting the MT-TL1 gene mutations is crucial. DNA Labs UAE offers a specialized genetic test for identifying mutations in the MT-TL1 gene, which is essential for confirming the diagnosis of MELAS syndrome and related mitochondrial disorders. This test is particularly valuable for patients showing symptoms of MELAS syndrome or those with a family history of mitochondrial diseases.
The cost of the MT-TL1 gene-related genetic test at DNA Labs UAE is 4400 AED. This test provides critical insights into the genetic underpinnings of MELAS syndrome, enabling personalized treatment plans and genetic counseling for affected families. It involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific mutations in the MT-TL1 gene that are known to cause the syndrome.
By offering this test, DNA Labs UAE plays a vital role in the diagnosis and management of MELAS syndrome, helping patients and their families navigate the complexities of this mitochondrial disorder with informed medical and genetic information.
The FLNA gene Melnick-Needles syndrome genetic test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the FLNA gene, which are responsible for Melnick-Needles syndrome (MNS). MNS is a rare genetic disorder characterized by distinctive skeletal abnormalities, facial features, and other systemic involvements. The FLNA gene plays a crucial role in cell structure and movement, and mutations in this gene can lead to the manifestations associated with MNS.
This genetic test involves analyzing the patient's DNA to identify mutations in the FLNA gene that are indicative of Melnick-Needles syndrome. Early diagnosis through this test can aid in the management and treatment of the syndrome, allowing healthcare providers to address symptoms more effectively and improve the quality of life for affected individuals.
The cost of the FLNA gene Melnick-Needles syndrome genetic test at DNA Labs UAE is 4400 AED. The test is conducted by experienced professionals who specialize in genetic diagnostics, ensuring accurate and reliable results. Patients seeking this test may require a referral from a healthcare provider, and it is recommended to discuss the potential benefits and implications of genetic testing with a genetic counselor or specialist prior to undergoing the test.
The CASK Gene Mental Retardation and Microcephaly with Pontine and Cerebellar Hypoplasia Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the CASK gene. These mutations are known to cause a rare genetic disorder characterized by significant intellectual disability, reduced head size (microcephaly), and underdevelopment (hypoplasia) of specific parts of the brain, notably the pons and cerebellum. The condition, which can affect individuals of any gender, has a profound impact on neurological development and physical growth.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any abnormalities in the CASK gene. This gene plays a crucial role in brain development and function, and its mutations can lead to the symptoms observed in affected individuals.
Offered at a cost of 4400 AED, this genetic test is crucial for early diagnosis and intervention. Identifying the genetic basis of the condition allows for a better understanding of the disorder, aids in making informed decisions about care and management, and provides valuable information for family planning. DNA Labs UAE, with its state-of-the-art facilities and experienced professionals, ensures accurate and reliable testing, providing essential support to affected families in managing this challenging condition.
The ELK1 Gene Mental Retardation Non-Syndromic Genetic Test is a specialized diagnostic assessment designed to identify mutations in the ELK1 gene, which have been associated with non-syndromic mental retardation. This form of mental retardation does not present with the additional physical or behavioral characteristics that are often associated with other genetic syndromes. The test aims to provide crucial information for the diagnosis and potential management of individuals with intellectual disabilities that may be linked to genetic abnormalities in the ELK1 gene.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test ensures accuracy and confidentiality in handling patient samples. With a cost of 4400 AED, the test is accessible for those who seek a deeper understanding of their genetic makeup, especially for families with a history of non-syndromic mental retardation. By identifying specific genetic mutations, healthcare providers can offer more personalized care plans and support for affected individuals and their families.
The "KLF8 Gene Mental Retardation Non-Syndromic Genetic Test" is a specialized diagnostic tool designed to identify mutations in the KLF8 gene, which have been associated with non-syndromic mental retardation. This condition is characterized by intellectual disabilities that occur without other significant physical or behavioral abnormalities. The KLF8 gene plays a crucial role in brain development and function, and mutations in this gene can lead to various neurodevelopmental disorders.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. It involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing techniques to detect any abnormalities or mutations in the KLF8 gene.
The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations and provide reliable results. This test is particularly valuable for families seeking a deeper understanding of intellectual disabilities with an unknown cause, as it can provide crucial information for diagnosis, management, and treatment planning.
The "NXF5 Gene Mental Retardation Non-Syndromic Genetic Test" is a specialized diagnostic tool designed to identify mutations in the NXF5 gene, which have been linked to non-syndromic mental retardation. This condition is characterized by intellectual disabilities that occur without additional physical or neurological symptoms typically associated with syndromic forms of mental retardation. The test is conducted by extracting a DNA sample from the patient, which is then analyzed in a laboratory setting to detect any abnormalities or mutations in the NXF5 gene that could be responsible for the condition.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test is crucial for families seeking to understand the genetic basis of intellectual disabilities in their loved ones. It can provide essential information for making informed decisions about care, support, and potential therapies. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed reporting that accompanies this advanced genetic assessment. By identifying specific genetic mutations, the test not only aids in the diagnosis of non-syndromic mental retardation but also contributes to a broader understanding of the genetic factors involved in intellectual disabilities.
